Medline has promoted executive Jim Boyle to serve as its next chief executive officer (CEO), and executive Jim Pigott to serve as its next president and chief operating officer (COO), effective October 1, 2023.
As part of the transition, current CEO Charlie Mills, President Andy Mills, and COO Jim Abrams will retire from their current roles, according to the company. All three will continue to serve the company on its Board of Directors, with Charlie Mills leading as Chairman of the Board and Andy Mills and Jim Abrams as Vice Chairmen, Medline reported.
“Jim Boyle and Jim Pigott have been instrumental in Medline’s growth and success during their nearly 60 years combined within the organization, and we are excited for them to lead us into the future,” said Charlie Mills, current chief executive officer of Medline. “In blending Medline’s high-performance culture and customer-centric approach with their extensive understanding of healthcare, they are perfectly suited to propel Medline forward while continuing to build upon our rich legacy.”
Founded in 1966, Medline is a global healthcare company with 56 years of consecutive sales growth, more than $21 billion in annual sales, over 35,000 employees, and is consistently recognized as a top workplace. Medline is a vertically integrated manufacturer and a market leader in medical-surgical distribution, serving the breadth of healthcare systems across the entire continuum of care. Its expanding clinical solutions and broad product portfolio, which includes manufacturing over half of the surgical procedure trays used in the United States, have firmly established Medline as a premier supply chain partner. Since 2018, Medline has invested $2 billion in its infrastructure to bolster the resiliency of the healthcare supply chain. Through a commitment to ongoing expansion into new markets, product categories and strategic partnerships, the company will continue to empower providers with the resources needed to deliver optimal care.
“I am incredibly honored by this opportunity. I want to express my gratitude to the Mills family for their years of leadership and for the confidence placed in me to guide this organization forward,” said Jim Boyle. “Medline has always been a company that operates in a nimble and agile manner, doing whatever is best for our customers and our employees, and I look forward to ensuring we continue to do so for years to come.”
“I am proud of all that Medline and the Mills family have accomplished through the years for our customers, the healthcare industry, and especially in cultivating our winning company culture,” said Jim Pigott. “I am grateful for this opportunity, and as we continue to find solutions to healthcare’s evolving challenges, I remain committed to doing so while preserving and building upon our company heritage.”
Medline has elevated company executives Jim Boyle (left) to serve as the next Chief Executive Officer, and Jim Pigott as the next President & Chief Operating Officer, effective October 1, 2023
CEO, Jim Boyle
Boyle joined Medline in 1996 and has served as Executive Vice President since 2018, managing its customer base of over 5,000 healthcare providers across the continuum of care and overseeing more than $21 billion of annual sales. Boyle was responsible for the strategic direction and execution of the commercial functions across all healthcare segments, as well as the Marketing, Operations and Logistics departments. In addition, he oversaw Medline’s distributed products business and led the customer support infrastructure, meeting the unique challenges of Medline’s customer base and its patient communities. During his career at the company Boyle progressed throughout the organization, holding various leadership roles including Division Vice President and Senior Vice President of the Acute Care segment, before being named Executive Vice President. Boyle received a Bachelor of Science degree in Industrial Distribution from Texas A&M University.
President and COO, Jim Pigott
Pigott joined Medline in 1992 and most recently served as Executive Vice President. In this role, he oversaw the strategy and execution of Medline’s 27 product divisions, comprised of more than 20 manufacturing sites and 14,000 employees. In addition, Pigott led Medline’s global sourcing and inventory management organizations. Over the years, he was involved in the company’s expansion into several product segments, including surgical, laboratory, diagnostics and cardiology, as well as the growth of its domestic manufacturing footprint. Pigott also spearheaded Medline’s global sourcing partnerships strategy while serving as the President of Medline Asia for four years. During his career at the company Pigott held additional leadership roles, including Division President and Group President, prior to being named Executive Vice President. Pigott received a Bachelor of Arts degree from the University of Michigan in Ann Arbor.